miR-24 promotes glioma development by acting on the caudal-type homeobox 1 (CDX1) target to activate the PI3K/Akt signaling pathway, promote cell proliferation, and induce apoptosis (Lei et al., 2021). The gene discussed is AKT1; the disease is central nervous system cancer.